Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver disease.
Loomba R, Clark G, Teckman J, Ajmera V, Behling C, Brantly M, Brenner D, D'Armiento J, Fried MW, Iyer JS, Mandorfer M, Rockey DC, Tincopa M, Vuppalanchi R, Younossi Z, Krag A, Turner AM, Strnad P. Loomba R, et al. Among authors: fried mw. Aliment Pharmacol Ther. 2024 May;59(10):1183-1195. doi: 10.1111/apt.17967. Epub 2024 Mar 22. Aliment Pharmacol Ther. 2024. PMID: 38516814 Review.
Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results.
Lauritsen K, Devière J, Bigard MA, Bayerdörffer E, Mózsik G, Murray F, Kristjánsdóttir S, Savarino V, Vetvik K, De Freitas D, Orive V, Rodrigo L, Fried M, Morris J, Schneider H, Eklund S, Larkö A; Metropole study results. Lauritsen K, et al. Aliment Pharmacol Ther. 2003 Feb;17(3):333-41. doi: 10.1046/j.1365-2036.2003.01464.x. Aliment Pharmacol Ther. 2003. PMID: 12562445 Free article. Clinical Trial.
Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results.
Lauritsen K, Devière J, Bigard MA, Bayerdörffer E, Mózsik G, Murray F, Kristjánsdóttir S, Savarino V, Vetvik K, De Freitas D, Orive V, Rodrigo L, Fried M, Morris J, Schneider H, Eklund S, Larkö A. Lauritsen K, et al. Aliment Pharmacol Ther. 2003 Feb;17 Suppl 1:24; discussion 25-7. Aliment Pharmacol Ther. 2003. PMID: 12614304 Free article. Clinical Trial.
Genetic polymorphisms associated with smoking behaviour predict the risk of surgery in patients with Crohn's disease.
Lang BM, Biedermann L, van Haaften WT, de Vallière C, Schuurmans M, Begré S, Zeitz J, Scharl M, Turina M, Greuter T, Schreiner P, Heinrich H, Kuntzen T, Vavricka SR, Rogler G, Beerenwinkel N, Misselwitz B; Swiss IBD Cohort Study Group. Lang BM, et al. Aliment Pharmacol Ther. 2018 Jan;47(1):55-66. doi: 10.1111/apt.14378. Epub 2017 Oct 20. Aliment Pharmacol Ther. 2018. PMID: 29052254
Patient-reported symptoms and interest in symptom monitoring in HCC treated with locoregional therapies: A qualitative study.
Moon AM, Cook S, Swier RM, Sanoff HK, Kappelman MD, Wagner LI, Barritt AS 4th, Singal AG, Shah ND, Mauro DM, Yanagihara TK, Gerber DA, Fried MW, Brown C, Waheed M, Teal R, Evon DM. Moon AM, et al. Among authors: fried mw. Hepatol Commun. 2023 Nov 6;7(11):e0315. doi: 10.1097/HC9.0000000000000315. eCollection 2023 Nov 1. Hepatol Commun. 2023. PMID: 37930127 Free PMC article.
Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET study.
Aleyadeh W, Verna EC, Elbeshbeshy H, Sulkowski MS, Smith C, Darling J, Sterling RK, Muir A, Akushevich L, La D, Terrault N, Fried MW, Feld JJ. Aleyadeh W, et al. Among authors: fried mw. Am J Transplant. 2024 Mar;24(3):468-478. doi: 10.1016/j.ajt.2023.10.006. Epub 2023 Oct 21. Am J Transplant. 2024. PMID: 37871798 Free article.
237 results